| human | Q5 |
| P227 | GND ID | 1146701187 |
| P213 | ISNI | 0000000062057505 |
| 0000000409012614 | ||
| P1006 | Nationale Thesaurus voor Auteursnamen ID | 148234453 |
| P7293 | PLWABN ID | 9810565841205606 |
| P4012 | Semantic Scholar author ID | 10045600 |
| P214 | VIAF ID | 89306079 |
| P166 | award received | Marcel-Piché Prize | Q3405012 |
| P27 | country of citizenship | Canada | Q16 |
| P108 | employer | Hotel Dieu Hospital | Q14875194 |
| P735 | given name | Wojciech | Q2588339 |
| Wojciech | Q2588339 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q34065336 | A decreased metabolic clearance rate of aldosterone in benign essential hypertension |
| Q54163646 | A dissociated effect of amino-glutethimide on the mineralocorticoid secretion in man. |
| Q73843494 | A new color reaction for 17-hydroxycorticoids and related compounds |
| Q74457247 | A new paper chromatographic system for the separation of polar corticosteroids |
| Q54415703 | Absence of plasma protein binding of aldosterone in normal and estrogen-treated rabbit. |
| Q72030769 | Acute changes in plasma volume, renin activity, and free aldosterone levels in healthy subjects following Fursemide administration |
| Q78846618 | Adrenocortical hormones in human hypertension and their relation to angiotensin |
| Q45042167 | Age- and posture-related changes in plasma protein binding and metabolism of aldosterone in essential and secondary hypertension |
| Q40009027 | Aldosterone and electrolyte balance in human hypertension |
| Q34033397 | Aldosterone and renin in essential hypertension |
| Q67455483 | Aldosterone-Binding Proteins in Human Plasma |
| Q54488770 | Aldosterone-binding globulin-induced hypertension in the rat. A new experimental model |
| Q44133853 | An excess of dopamine in postsympathectomy orthostatic hypotension. Treatment with a dopa-decarboxylase inhibitor |
| Q70699495 | Animal-experiment studies in dogs on the influencing of aldosterone secretion through changed plasma magnesium concentration |
| Q68767671 | Association of decreased plasma cortisol and corticosteroid-binding globulin binding capacity in patients with essential hypertension and their first degree relatives |
| Q67560858 | Catecholamine excretion in "idiopathic" edema: decreased dopamine excretion, a pathogenic factor? |
| Q74522921 | Chemical method for the determination of urinary aldosterone |
| Q74245040 | Detailed study of a purified urinary aldosterone fraction |
| Q69340022 | Digoxin-like immunoreactivity, displacement of ouabain and inhibition of Na+/K+ ATPase by four steroids known to be increased in essential hypertension |
| Q43438982 | Dissociation of plasma renin activity and aldosterone in essential hypertension |
| Q43762151 | Diurnal Variation of Plasma Vasopressin in Man* |
| Q39958479 | Dynamic aldosterone and 18-hydroxydeoxycorticosterone studies in labile and stable benign essential hypertension |
| Q43553251 | Effect of Propranolol on Plasma Renin Activity, Renal Cortex Renin, and Adrenal and Brain Isorenins in Rats |
| Q52730450 | Effect of adrenal arterial infusion of different Mg 2+ concentrations on the spontaneous release of catecholamines in the anesthetized dog. |
| Q39996107 | Effects of ACTH on Steroid Metabolism |
| Q40119195 | Effects of acth and posture on aldosterone metabolism in essential hypertension |
| Q34361031 | Effects of angiotensin II on steroid metabolism and hepatic blood flow in man |
| Q79034724 | Effects of angiotensin infusions on urinary excretion of compound III and substances other than aldosterone |
| Q67321646 | Efficient method for purifying progesterone for competitive protein-binding technique |
| Q79248772 | Electrolyte and corticosteroid studies in a 15-year-old girl with primary aldosteronism and malignant hypertension |
| Q54642761 | Evidence of in vivo inhibition of 11-beta-hydroxylation of steroids by dehydroepiandrosterone in the dog. |
| Q71038094 | Experimental essential hypertension in the rat? |
| Q67006559 | Free and conjugated dopamine in pheochromocytoma, primary aldosteronism and essential hypertension |
| Q68423436 | Further evidence of altered adrenocortical function in hypertension. Dehydroepiandrosterone excretion rate |
| Q50925162 | Further studies on human plasma aldosterone-binding globulins: isolation, purification, and evidence for heterogeneity. |
| Q74014949 | Further studies on the absorption spectra of steroids in 100% phosphoric acid |
| Q74833351 | Further studies on urinary aldosterone in human arterial hypertension |
| Q66946096 | Genetic aspects of plasma aldosterone binding globulins in families of patients with essential hypertension, including isolation of novel thermostable homologues from plasma and urine |
| Q73942916 | Human arterial hypertension: a state of mild chronic hyperaldosteronism? |
| Q70023551 | Human salivary or plasma aldosterone- and dehydroepiandrosterone-binding glycoprotein induces hypertension in the rat |
| Q54646515 | Hypertension with adrenal, genital, renal defects, and deafness. A new familial syndrome. |
| Q67335697 | Hypertension with renal arterial stenosis: Humoral, hemodynamic and histopathologic factors |
| Q40469789 | Increased Aldosterone Plasma Protein Binding in Women on Combined Oral Contraceptives throughout the Menstrual Cycle* |
| Q35743188 | Influence of dextro-thyroxine and androsterone on blood clotting factors and serum cholesterol in patients with atherosclerosis. |
| Q68691215 | Influence of sodium, potassium, and pituitary hormones on iso-renin in rat adrenal glands |
| Q78269376 | Isolation of a steroid-like substance from urine and citrous fruits |
| Q69680206 | Isolation of aldosterone urinary metabolites, glucuronides and sulfate |
| Q39622267 | Jeremiah Metzger lecture, 1974: The renin-angiotensin system. Some new aspects |
| Q66907537 | Letter: Plasma prolactin: effect of posture in hypertensive patients |
| Q39739204 | Low-renin hypertension: classification, mechanisms and therapy |
| Q39987460 | Malignant hypertension with hypokalemia in a patient with renin-producing pulmonary carcinoma |
| Q68899166 | Metabolism of pregnenolone and pregnenolone sulphate in benign essential hypertension |
| Q78949777 | Method for determination of urinary 5 beta, -pregnane-3 alpha, 17 alpha, 20 alpha -triol and delta 5-pregnene-3 beta, 17 alpha, 20 alpha -triol |
| Q78637408 | Microdetermination of corticosteroids with tetrazolium derivatives |
| Q67327603 | Mineralocorticoid activity in patients in the early benign phase of essential hypertension |
| Q45106734 | Mineralocorticoid secretion in essential hypertension with normal and low plasma renin activity |
| Q46399307 | Mineralocorticoids and essential hypertension |
| Q36739015 | New evidences of disturbances of mineralocorticoid activity in benign, uncomplicated essential hypertension |
| Q39807816 | Origin of Urinary 16β-Hydroxydehydroepiandrosterone in Essential Hypertension |
| Q79374438 | Parallel biochemical and histochemical studies of an adrenocortical adenoma from a patient with primary aldosteronism |
| Q69833996 | Plasma cortisol and corticosteroid-binding globulin in essential hypertension |
| Q39989289 | Plasma cyclic adenosine 3':5'-monophosphate response to isoproterenol and glucagon in hyperkinetic borderline (labile) hypertension |
| Q40009946 | Plasma deoxycorticosterone and aldosterone in essential hypertension |
| Q35957676 | Plasma progesterone and aldosterone in pregnancy |
| Q67294777 | Plasma progesterone in normal subjects and patients with benign essential hypertension on normal, low, and high sodium intake |
| Q69732892 | Plasma steroids in rats with experimental ectopic pituitary tumor and arterial hypertension |
| Q68574753 | Procedure for determination of aldosterone in human peripheral plasma by double-isotope derivative assay, and its application for measurement of secretory rate and urinary excretion |
| Q52994216 | Procedure for simultaneous determination of secretion rates of deoxycorticosterone and corticosterone by double-isotope derivative assay. |
| Q48570743 | Proceedings: Iso-renin in adrenal glands of rats: a possible factor in steroid production. |
| Q68689407 | Radioimmunoassay for aldosterone and normal values under various physiological conditions |
| Q73826442 | Recovery of aldosterone, hydrocortisone and cortisone following dialysis |
| Q72847462 | Renal vasodepressor lipid |
| Q52849142 | Renin angiotensin aldosterone axis, including aldosterone binding globulin and blood pressure in three species of nonhuman primates. |
| Q42417316 | Renin in hypertension: how important as a risk factor? |
| Q67213808 | Renin-Aldosterone System in Parkinson's Disease |
| Q40050300 | Response of Several Adrenal Steroids to ACTH Stimulation in Essential Hypertension |
| Q44938197 | Role of dopamine in the regulation of arterial pressure and sodium excretion. Physiopathological and clinical implications |
| Q35672684 | Role of the adrenal cortex and sodium in the pathogenesis of human hypertension |
| Q35939068 | Screening programs for hypertension |
| Q68470919 | Secretion rate of dehydroepiandrosterone and dehydroepiandrosterone sulfate in benign essential hypertension as compared to normal subjects |
| Q40231820 | Selective Hypopituitarism with Severe Hyponatremia and Secondary Hyporeninism* |
| Q69921650 | Serum aldosterone and protein-binding variables in Yanomama Indians: a no-salt culture as compared to partially acculturated Guaymi Indians |
| Q93658787 | Simple reproducible competitive radioligand assay for plasma protein binding of aldosterone |
| Q67700075 | Specific aldosterone-binding proteins in human plasma: partial characterisation |
| Q39733955 | Splanchnic blood flow in essential hypertension and in hypertensive patients with renal artery stenosis |
| Q78846616 | Studies of the pathogenesis of human hypertension. The adrenal cortex and renal pressor mechanism |
| Q79374437 | Studies on the in vitro production of corticosteroids by adrenal glands from normotensive individuals and hypertensive patients |
| Q71465517 | Studies on the mechanism of experimental congestive heart failure in dogs |
| Q78846621 | Study of a large steroid spectrum in normal subjects and hypertensive patients |
| Q34008248 | THE EFFECTS OF INTRAVENOUS INFUSIONS OF VALINE-5 ANGIOTENSIN II AND OTHER PRESSOR AGENTS ON URINARY ELECTROLYTES AND CORTICOSTEROIDS, INCLUDING ALDOSTERONE. |
| Q37103842 | The Adrenal Cortex and Essential Hypertension |
| Q73843449 | The absorption spectra of steroids in 100% phosphoric acid |
| Q35898283 | The angiotensin infusion test and peripheral venous renin activity |
| Q79453276 | The isolation of 6beta-hydroxycorticosterone and its 11-dehydro derivative from the adrenal gland, adrenal adenoma, and urine of a patient with primary hyperaldosteronism |
| Q78899802 | The metabolism of aldosterone by surviving dog and human liver slices |
| Q57139089 | The relationship of plasma aldosterone-binding globulin to blood pressure regulation in young adults with cystic fibrosis |
| Q40110021 | The renin-angiotensin system and the adrenal cortex in human essential hypertension |
| Q40067651 | The role of the adrenal cortex in human essential hypertension: keynote address |
| Q78495322 | URINARY EXCRETION OF DELTA-5-PREGNENE-3-BETA, 17-ALPHA, 20-ALPHA-TRIOL IN NORMAL SUBJECTS AND HYPERSENSITIVE PATIENTS |
| Q79380045 | [Action of dextro-thyroxine and androsterone on blood cholesterol and coagulation factors in atherosclerosis.] |
| Q70441067 | [Effect of experimentally altered plasma-magnesium concentration on aldosterone secretion in dogs] |
| Q68643606 | [Enzyme deficiencies in pathogenesis of hypertension] |
| Q71842974 | [Inhibition of mineralocorticoid secretion by aminoglutethimide and its usefulness in the therapy of edema] |
| Q79380047 | [The effect of dextrothyroxin and androsterone on serum cholesterol and the coagulation factors in atherosclerotics] |
Search more.